MLAB (Mesa Laboratories) LT-Debt-to-Total-Asset: 0.34 (As of Mar. 2026)

What is Mesa Laboratories LT-Debt-to-Total-Asset?

Mesa Laboratories MLAB +4.32% 77 LT-Debt-to-Total-Asset is 0.34 as of Mar. 2026. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.05 (Modestly Undervalued). The stock has 7 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Mesa Laboratories's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.34.

Mesa Laboratories's long-term debt to total assets ratio increased from Mar. 2025 (0.18) to Mar. 2026 (0.34). It may suggest that Mesa Laboratories is progressively becoming more dependent on debt to grow their business.

Mesa Laboratories (NAS:MLAB) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Mesa Laboratories LT-Debt-to-Total-Asset Related Terms

Mesa Laboratories LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Mesa Laboratories's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesa Laboratories LT-Debt-to-Total-Asset Chart

Mesa Laboratories Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.31

0.28

0.50

0.18

0.34

Mesa Laboratories Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.18	0.21	0.42	0.40	0.34

77GF Score

Mesa Laboratories Inc MLAB

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Mesa Laboratories LT-Debt-to-Total-Asset Calculation

Mesa Laboratories's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )	/	Total Assets (A: Mar. 2026 )
	=	145.857	/	427.747
	=	0.34

Mesa Laboratories's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	145.857	/	427.747
	=	0.34

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.34 mean?

Mesa Laboratories (MLAB) has a LT-Debt-to-Total-Asset of 0.34 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Mesa Laboratories and its competitors.

Is Mesa Laboratories' LT-Debt-to-Total-Asset too high?

Mesa Laboratories' current LT-Debt-to-Total-Asset is 0.34. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Mesa Laboratories' LT-Debt-to-Total-Asset compare to AERG and MVIS?

Mesa Laboratories' LT-Debt-to-Total-Asset of 0.34 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Hardware company?

A good LT-Debt-to-Total-Asset depends on the Hardware industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Mesa Laboratories and its competitors. Mesa Laboratories's current LT-Debt-to-Total-Asset is 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mesa Laboratories stock overvalued right now?

Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.05, compared to a current price of $102.42 — trading 11.7% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.34. Mesa Laboratories' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current LT-Debt-to-Total-Asset is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mesa Laboratories (MLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued. The current stock price of $102.42 is trading 11.7% below its estimated GF Value™ of $116.05. GuruFocus considers Mesa Laboratories to be Modestly Undervalued.

Key valuation signals for MLAB:

LT-Debt-to-Total-Asset: 0.34
GF Value™: $116.05 vs. price of $102.42 (11.7% below fair value)
GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mesa Laboratories Business Description

Industry Technology Hardware

Comparable Companies AERG MVIS ARBE USBC GNSS ASTC SOTK ODYS WRAP MIND TSE:6861 COHR KEYS GRMN TPE:2360 TDY OSTO:HEXA B MKSI FTV TRMB

Address 12100 West Sixth Avenue, Lakewood, CO, USA, 80228

Website https://www.mesalabs.com

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

77GF Score

Get the complete analysis for MLAB

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$102.42

Price

$116.05

GF Value

View MLAB Analysis

See LT-Debt-to-Total-Asset data for all stocks →